Penglai Zhao

Dr. Penglai Zhao

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2023 in Frontiers in Neurology
Verified
Journal Article
Open access
MXManman Xu
Manman Xu
LZLiang Zhang
Liang Zhang
JWJuan Wang
Juan Wang
LCLongyang Cheng
Longyang Cheng
CCChunlei Chen
Chunlei Chen
CHChun-Hua Hang
Chun-Hua Hang
Background and objective: Post-operative pneumonia (POP), a common complication, may be associated with prolonged hospitalization and long-term mortality in aneurysmal subarachnoid hemorrhage (aSAH) patients. This study aimed to explore the association between pre-operative prognostic nutrition index (PNI) and POP in aSAH patients.Methods: A total of 280 aSAH patients were enrolled from Nanjing Drum Tower Hospital. PNI was calculated as follows: [10 × albumin(gr/dl)] + [0.005 × absolute pre-operative lymphocyte count (per mm3)]. We utilized multivariate analyses, restricted cubic spline, net reclassification improvement (NRI), and integrated discrimination improvement (IDI) to elucidate the role of PNI in POP.Results: Pre-operative PNI levels in the POP group were higher, compared with the non-POP group (41.0 [39.0, 45.4] vs. 44.4 [40.5, 47.3], P = 0.001). When we included PNI as a categorical variable in the multivariate analysis, the levels of PNI were associated with POP (odds ratio, 0.433; 95% confidence interval, 0.253–0.743; P=0.002). In addition, when we included PNI as a continuous variable in the multivariate analysis, the PNI levels were also associated with POP (odds ratio, 0.942; 95% confidence interval, 0.892–0.994; P = 0.028). The level of albumin was also a predictor of the occurrence of POP, with a lower diagnostic power than PNI [AUC: 0.611 (95% confidence interval, 0.549–0.682; P = 0.001) for PNI vs. 0.584 (95% confidence interval, 0.517–0.650; P = 0.017) for albumin]. Multivariable-adjusted spline regression indicated a linear dose–response association between PNI and POP in aSAH participants (P for linearity = 0.027; P for non-linearity = 0.130). Reclassification assessed by IDI and NRI was significantly improved with the addition of PNI to the conventional model of POP in aSAH patients (NRI: 0.322 [0.089–0.555], P = 0.007; IDI: 0.016 [0.001–0.031], P = 0.040).Conclusion: The lower levels of pre-operative PNI may be associated with the higher incidence of POP in aSAH patients. Neurosurgeons are supposed to pay more attention to pre-operative nutrition status in aSAH patients.

28 January 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
YYYongbo Yang
Yongbo Yang
YPYuchun Pan
Yuchun Pan
CCChunlei Chen
Chunlei Chen
PZPenglai Zhao
Penglai Zhao
CHChunhua Hang
Chunhua Hang
Objective: The present study aimed to investigate the clinical significance of multiparameter intracranial pressure (ICP) monitoring in the prediction of the prognosis of hypertensive intracerebral hemorrhage (HICH). Methods: A retrospective analysis was performed on the clinical data of 53 HICH patients. The patients underwent removal of intracranial hemorrhage and decompressive craniectomy after admission. A ventricular ICP monitoring probe was used to continuously and invasively monitor mean arterial pressure (MAP) and ICP after surgery. The NEUMATIC system was used to collect ICP data, including pressure reactivity index (PRx), ICP dose (DICP), amplitude and pressure regression (RAP), and cerebral perfusion pressure (CPP). The mean PRx, CPP, RAP, ICP, and DICP20 mmHg × h were calculated with 1 h as the time segment. According to the Glasgow outcome scale (GOS) scores after discharge, the patients were grouped into the poor prognosis group (GOS I–III) and the good prognosis group (GOS IV and V). The two groups were compared in terms of GOS scores in the treatment and prediction of prognosis of patients. Results: The good prognosis group showed significantly lower values of mean ICP, DICP20 mmHg × h, RAP, and PRx than the poor prognosis group, while CPP was significantly higher (p < 0.001). Conclusions: PRx, DICP, RAP, and CPP could reflect intracranial changes in patients and were significantly correlated with the prognosis of the patients. Mean ICP, PRx, DICP20 mmHg × h, and RAP were negatively correlated with prognosis, while CPP was positively correlated with prognosis.

1 August 2017 in Translational Cancer Research
Verified
Journal Article
Closed access
PDF file
XLXiaoyang Ling
Xiaoyang Ling
TZTongming Zhu
Tongming Zhu
ZLZhengxiang Luo
Zhengxiang Luo
YZYansong Zhang
Yansong Zhang
YCYongyan Chen
Yongyan Chen
YSYibing Si
Yibing Si
Pituitary abscess (PA) is a rare lesion in the saddle area with a high rate of misdiagnosis. Because of its non-specific characteristics, PA is potentially responsible for high morbidity and mortality. Four patients over a 5-year period presented with headache, blurred vision and hormonal deficiencies, and none of them had undergone previous resection of pituitary lesions. In view of the characteristic MR findings, both PA and PA recurrence were included as potential diagnoses. Three patients underwent transsphenoidal drainage of the abscess, and one was subjected to a right pterional approach to remove the abscess. During the 2-year follow-up, two patients suffered from PA recurrence 2 months after discharge and required another operation. Because there are no unique characteristics of the specific imaging features, PA is easily confused with other pituitary diseases such as Rathke’s cyst and craniopharyngioma. With the advancement of techniques, surgical removal has proven to be an extremely effective treatment, which validates the diagnosis and guides future treatment plans.

3 January 2026 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
JWJuan Wang
Juan Wang
Haibo LiHaibo Li
Haibo Li
MXManman Xu
Manman Xu
WLWen‐Juan Li
Wen‐Juan Li
LCLongyang Cheng
Longyang Cheng
PZPenglai Zhao
Penglai Zhao
Background: Acute brain injury (ABI) often elevates intracranial pressure (ICP), yet static measurements miss dynamic risk. We evaluated the prognostic value of early ICP trajectories. Methods: We formed a multicenter ICU cohort from MIMIC‐IV (2008–2022), eICU (2014–2015), and NSICU (2024–2025). Latent class growth modeling identified ICP trajectories over the first 120 h. Associations with in‐hospital mortality were tested with Cox models, and incremental value beyond baseline clinical variables was quantified by AUC, integrated discrimination improvement (IDI), and net reclassification improvement (NRI). Sensitivity analyses were performed across datasets and age groups. Results: Among 1700 patients with ABI, four trajectories emerged—Severe Progressive, Stabilized Elevated, Mildly Elevated Stable, and Normal. Versus Normal, mortality risk was highest for Severe Progressive (HR 13.54; 95% CI 9.35–19.59), followed by Stabilized Elevated (HR 2.53; 1.83–3.49) and Mildly Elevated Stable (HR 1.48; 1.16–1.91). In patients aged ≥ 55 years, risk with Stabilized Elevated was amplified (HR 2.87; 1.97–4.20). Adding trajectories improved risk stratification (IDI +0.065; NRI +0.201) with modest AUC gains. Conclusions: Early ICP trajectories define reproducible phenotypes with distinct mortality risk. Incorporating trajectories—particularly the stabilized‐elevated pattern in older adults—adds prognostic value beyond clinical variables and supports prospective validation.

22 August 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JWJuan Wang
Juan Wang
JSJia-Qing Sun
Jia-Qing Sun
YLYue Lu
Yue Lu
QYQi-Lin Yang
Qi-Lin Yang
PZPenglai Zhao
Penglai Zhao
WLWei Li
Wei Li
Acute brain injury (ABI) is a leading cause of ICU admission and mortality. Effective sedation is essential for preventing secondary brain injury, and dexmedetomidine has emerged as a potential neuroprotective agent. We conducted a retrospective analysis using the MIMIC-IV v3.1 database, including adult patients admitted to the ICU with ABI. Patients were divided into two groups based on whether they received dexmedetomidine. Propensity score matching (PSM), weighting methods, and doubly robust estimation were used to adjust for confounding factors. Results from the doubly robust analysis showed that dexmedetomidine use was significantly associated with reduced in-hospital mortality (HR: 0.41, 95% CI: 0.35–0.48, p < 0.001) and ICU mortality (HR: 0.34, 95% CI: 0.28–0.41, p < 0.001). Additionally, dexmedetomidine was associated with significantly increased vasopressor-free days (MD: 2.64, 95% CI: 1.98–3.30, p < 0.001) and ventilation-free days (MD: 2.23, 95% CI: 1.59–2.86, p < 0.001). Further mediation analysis indicated that delirium mediated 37% of the effect of dexmedetomidine on in-hospital mortality and 60% of its effect on ICU mortality. This suggests that delirium may be a key mediator of dexmedetomidine’s beneficial effects, consistent with its potential advantages in sedation and neuroprotection observed in previous studies. In conclusion, dexmedetomidine use in ICU patients with ABI is associated with significantly lower mortality and improved clinical outcomes, with delirium acting as a critical mediator.

20 July 2026 in Neurocritical Care
Verified
Journal Article
Open access
PDF file
JWJuan Wang
Juan Wang
WDWei Dai
Wei Dai
MXMan-Man Xu
Man-Man Xu
CHChun-Hua Hang
Chun-Hua Hang
WLWen-Juan Li
Wen-Juan Li
PZPenglai Zhao
Penglai Zhao
Objective: The purpose of this study was to determine whether dynamic Glasgow Coma Scale (GCS) trajectories are associated with mortality risk and provide incremental prognostic information beyond selected baseline clinical variables in intensive care unit (ICU)-admitted patients with non-traumatic stroke (NTS). Methods: In this retrospective cohort study of 7876 patients from the MIMIC-IV, eICU, and NSICU databases, latent class growth modeling (LCGM) was used to identify GCS trajectories. The associations of trajectory groups and threshold-based GCS metrics with in-hospital mortality were evaluated using multivariable Cox regression. The incremental value of trajectories was assessed using variable sets selected by Boruta, least absolute shrinkage and selection operator (LASSO), and best subset selection (BSS). Results: Four distinct GCS trajectories were identified: stable high (35.7%), rapid improvement (38.0%), persistent moderate (18.8%), and persistent low (7.5%). Compared with the stable high group, mortality risk increased stepwise in fully adjusted models, with HRs of 2.94 (95% CI 2.24–3.84), 8.11 (95% CI 6.18–10.66), and 17.72 (95% CI 13.30–23.59) for rapid improvement, persistent moderate, and persistent low, respectively. Threshold-based mean GCS AUC metrics were also associated with in-hospital mortality. A distinct gradual deterioration trajectory was observed in elderly patients (≥ 65 years). Adding GCS trajectories to the Boruta-selected baseline model improved predictive performance, increasing the AUC from 0.800 to 0.860, with an IDI of 0.085 and a continuous NRI of 0.283 (all P < 0.001). Conclusions: Trajectory-based and threshold-based longitudinal GCS assessments were strongly associated with in-hospital mortality in critically ill patients with NTS, supporting the value of dynamic GCS monitoring as a complementary tool for risk stratification in neurocritical care. Graphical Dynamic GCS monitoring in 7876 ICU-admitted patients with non-traumatic stroke identified four distinct trajectory patterns in the overall cohort, with a gradual deterioration pattern observed only in elderly patients (≥ 65 years). Threshold-based AUC metrics quantified cumulative exposure above clinically relevant GCS thresholds. Both trajectory- and threshold-based approaches provided complementary prognostic information for mortality risk stratification.